glycyl-arginyl-glycyl-aspartyl-serine and Cancer of Cervix

glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, TF; Lin, CH; Peng, HC; Sheu, JR	1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Cancer of Cervix

Article	Year
Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism. Peptides, 1994, Volume: 15, Issue:8 Topics: Amino Acid Sequence; Cell Adhesion; Cell Survival; Crotalid Venoms; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Female; Fibronectins; Flow Cytometry; HeLa Cells; Humans; Kinetics; Molecular Sequence Data; Oligopeptides; Peptides; Thymidine; Uterine Cervical Neoplasms	1994

Article

Year

Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.

Peptides, 1994, Volume: 15, Issue:8

Topics: Amino Acid Sequence; Cell Adhesion; Cell Survival; Crotalid Venoms; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Female; Fibronectins; Flow Cytometry; HeLa Cells; Humans; Kinetics; Molecular Sequence Data; Oligopeptides; Peptides; Thymidine; Uterine Cervical Neoplasms

1994